Related Experiment Video
Updated: Jul 6, 2026
05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
REST in central nervous system tumors
Zuzanna Bieńkowska1, Maciej Ołdak2, Marta Maleszewska1
1Zakład Fizjologii Zwierząt, Instytut Zoologii Doświadczalnej, Wydział Biologii, Uniwersytet Warszawski, Warszawa.
Postepy Biochemii
|July 4, 2026
Summary
The transcription factor REST (RE1-silencing transcription factor) is crucial for brain development and CNS tumor growth. Its dysregulation promotes tumor progression, highlighting its potential as a therapeutic target.
Area of Science:
- Neuroscience
- Oncology
- Epigenetics
Background:
- The transcription factor REST (RE1-silencing transcription factor) regulates neuronal gene expression.
- REST is involved in normal brain development and central nervous system (CNS) tumor pathogenesis.
- REST functions in epigenetic gene silencing by binding RE1 sequences and recruiting repressive complexes.
Purpose of the Study:
- To elucidate the role of REST in CNS tumors.
- To investigate REST's context-dependent effects in tumorigenesis.
- To explore REST as a potential biomarker and therapeutic target for CNS tumors.
Main Methods:
- Analysis of REST's role in gene silencing.
- Investigation of REST's impact on neurogenesis and differentiation.
- Evaluation of REST's oncogenic functions in CNS tumors.
Main Results:
- REST acts as an oncogene in CNS tumors, promoting pro-tumor processes.
- Dysregulated REST expression supports tumor stem cell properties, proliferation, and invasiveness.
- REST influences angiogenesis, hypoxia adaptation, and the tumor microenvironment.
Conclusions:
- REST is a key player in CNS tumor development and progression.
- REST's multifaceted roles present it as a promising biomarker and therapeutic target.
- Targeting REST may offer novel treatment strategies for CNS tumors.
Related Concept Videos
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:04Glial Cells
Overview
01:31Nervous Tissue: Glial Cells
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...
01:19Cranial and Spinal Meninges
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...